Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial.
Kanwal P RaghavBettzy StephenDaniel D KarpSarina A Piha-PaulDavid S HongDipti JainDilichukwu O Chudy OnwugajeAbdulrahman AbonofalAnneleis F WillettMichael OvermanBrandon SmagloRyan W HueyFunda Meric-BernstamGauri R VaradhacharyAung NaingPublished in: Journal for immunotherapy of cancer (2022)
NCT02721732.